FIELD: drug administration.
SUBSTANCE: improved immediate release solid dosage form of naproxen with a defined particle size distribution in the intragranular portion and a defined particle size distribution in the carbonate portion, which allows naproxen to remain in the solution and ensures rapid dissolution and rapid absorption of naproxen. The present invention provides a dosage form of naproxen which, when administered to the human body on an empty stomach for 10 minutes or less, provides an average plasma concentration of naproxen of at least 15-20 mcg/ml.
EFFECT: present invention provides methods of administering naproxen for the treatment of pain.
16 cl, 2 dwg, 8 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
ANTISENSE COMPOSITIONS AND METHODS FOR PRODUCTION AND USE THEREOF | 2009 |
|
RU2739302C2 |
ANTISENSE COMPOSITIONS AND METHODS FOR PRODUCTION AND USE THEREOF | 2009 |
|
RU2593939C2 |
PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR | 2019 |
|
RU2820820C2 |
METHOD OF TREATING VITAMIN B INSUFFICIENCY | 2008 |
|
RU2469728C2 |
PHARMACEUTICAL DRUG FORM FOR PERORAL INTRODUCTION TO REDUCE INTER-INDIVIDUAL VARIABILITY, IN PARACETAMOL-CONTAINING COMPOSITIONS IN PATIENT | 2009 |
|
RU2517139C2 |
DELAYED-RELEASE ORAL DOSAGE FORM OF GABAPENTIN | 2005 |
|
RU2440112C2 |
PASTILLE DOZED FORM | 2018 |
|
RU2771806C2 |
PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN | 2008 |
|
RU2484816C2 |
AMORPHOUS SOLID DISPERSION COMPRISING TAXANE, TABLET COMPRISING SAME, AND METHOD FOR PREPARING SAME | 2015 |
|
RU2684632C2 |
PHARMACEUTICAL COMPOSITIONS OF KETOROLAC | 2017 |
|
RU2677663C1 |
Authors
Dates
2023-04-28—Published
2020-03-16—Filed